SEC EDGAR Filings04/10 00:38 UTC4 - Cote Elissa S.Filed: 2026-04-09 AccNo: 0002069951-26-000004 Size: 11 KBInsider Ownership FilingVTGNU.S. Securities and Exchange CommissionVistagen Therapeutics, Inc.热度 106.3重要度 74情绪 0.00